Articles tagged with Bone Diseases
The UK National Osteoporosis Guideline Group has published a new guideline for the prevention and treatment of osteoporosis, which includes updated recommendations for vertebral fracture detection and anabolic treatment options. The guidance aims to improve service provision in both primary and secondary care settings.
The IOF Skeletal Rare Diseases Academy has awarded grants to six young researchers for their outstanding work on rare skeletal disorders. The awards recognize the importance of advancing knowledge and diagnosis for these conditions.
Professor René Rizzoli has been recognized for his significant and longstanding contribution to the advancement of osteoporosis research through his work on bone metabolism and mineralization. He is a respected researcher, clinician, and leader in the field of osteoporosis, with a strong focus on prevention and treatment.
The International Osteoporosis Foundation awarded Professor Thierry Thomas the IOF Committee of Scientific Advisors (CSA) Medal of Achievement for his outstanding scientific contributions to osteoporosis. The award recognizes his work on secondary fracture prevention and post-fracture care coordination programs.
Chronic liver injury triggers bone loss through the liver-bone axis, characterized by an imbalance of PP2Ac® and LCAT. This study reveals the molecular mechanisms behind HOD disease progression.
The American Roentgen Ray Society recognizes Drs. Nguyen, Beheshtian, Harfouch, and Hashiba for their outstanding research and education contributions to the field of radiology. The awards honor the candidates' scientific merit and potential impact on imaging and allied sciences research.
Survival rates for adult patients with relapsed acute lymphoblastic leukemia (ALL) after hematopoietic cell transplantation have increased significantly over the past two decades. The two-year overall survival rate rose from 27.8% in 2000-2004 to 54.8% in 2015-2019, despite a significant increase in patient age at relapse.
Researchers develop ice-inspired lubricant that enhances lubrication and reduces friction and inflammation in a rat model of osteoarthritis. The treatment, which uses microfluidic technology to create drug-loaded particles, shows promise as a potential solution for joint pain and degeneration.
A new study by researchers at Mount Sinai found that a specific gene, HHIP, helps regulate the development of the coronal suture, a fibrous joint that connects the front and middle bone plates. The study showed that embryos with a missing HHIP gene had misshapen skulls and fewer mesenchymal cells separating the bones.
Researchers at Hospital Gregorio Marañón and UC3M developed a navigation system combining surgical navigation, three-dimensional photography, and augmented reality to estimate bone fragment positions during surgery. This system has been used on 7 patients with optimal results, reducing dependency on surgeons' experience.
Researchers used next-generation DNA sequencing to detect residual disease in patients treated with CAR-T therapy for acute lymphoblastic leukemia. The study found that DNA sequencing was more sensitive and accurate than flow cytometry in predicting relapse, enabling earlier intervention.
A study by Tokyo University of Science researchers identifies a novel regulatory axis targeting dendritic cell activity, suppressing autoimmune disease symptoms and bone loss. They discovered DCIR binds to glycoproteins on macrophages and osteoclasts, reducing inflammation and immune responses.
Research suggests that obesity triggers inflammation, leading to an increase in myeloid-derived suppressor cells, which break down bone tissue. This can result in gum disease and tooth loss. The study found a significant link between high-fat diets and increased osteoclasts and alveolar bone destruction.
The study provides a unique genomic blueprint for understanding the complex mechanisms linking obesity with comorbidities like type 2 diabetes and cardiovascular diseases. The Ossabaw pig's genome is highly relevant to humans, making it an ideal model for studying human obesity.
Researchers at Universitat Autonoma de Barcelona develop gene therapy that fully corrects severe whole-body alterations in Morquio A disease, a rare condition caused by GALNS enzyme deficiency. The therapy, administered via intravenous viral vector, prevents bone malformations and life-threatening complications.
A study published in Current Rheumatology Reviews found that rehabilitation exercises significantly improved functional strength and reduced weight in knee osteoarthritis patients. The researchers also noted an increase in exercise adherence among the rehabilitation group compared to the control group.
Researchers created the first detailed cell-by-cell description of how the coronal suture develops, identifying new genes and cell types involved in generating stem cells that grow skull bones. The study aims to advance new interventions for patients with craniosynostosis.
Scientists have discovered a way to replace mutated osteoblasts with healthy ones, leading to improved collagen production and potentially paving the way for a cure for brittle bone disease. The breakthrough could be translated to other forms of OI and bone diseases in the future.
A preclinical study supports AAV8-TNAP-D10 as a single-dose treatment for hypophosphatasia, extending the life span of mice with minimal side effects. The therapy may provide an alternative to current medication injections, benefiting patients with severe skeletal and dental abnormalities.
Scientists have created a miniature 3D bone marrow model that can predict patient responses to Eltrombopag therapy for platelet disorders. The model uses silk protein scaffolding and patient-derived cells to recreate human bone marrow conditions.
Researchers found that people with periodontitis are at higher risk of experiencing major cardiovascular events due to associated inflammation. Active gum disease was predictive of arterial inflammation, leading to heart attacks, strokes, and other cardiovascular complications.
Scientists regenerate parts of the skull using stem cells, correcting skull shape and reversing learning and memory deficits in young mice with craniosynostosis. The study holds great potential for less invasive therapies for children with this common birth defect.
Researchers identified a non-hereditary mutation in blood cells from a patient with GATA2 deficiency that may have prevented bone marrow failure and other clinical manifestations. The mutation acted as a kind of natural gene therapy, protecting the patient from developing typical symptoms.
Researchers at Uppsala University used synchrotron X-rays to study the organ of balance and surrounding blood vessels. The discovery of a drainage system may improve understanding of how Ménière's disease arises from fluid accumulation in the inner ear.
Researchers have identified a new gene, SMAD3, associated with melorheostosis, a rare condition causing excessive bone tissue growth. The study provides a breakthrough in understanding the disease's causes and may lead to the development of treatments.
A study published in the Journal of the Endocrine Society found that exercising women with menstrual disorders can start menstruating again by consuming an additional 300-400 calories a day. This strategy is easy to implement with the help of a nutritionist and avoids complications from drug therapy.
Researchers have found that Saussurea extract has antimicrobial properties and can speed up bone tissue regeneration. The study suggests using Saussurea to treat bacterial bone infections, which are resistant to antibiotics.
A 289-million-year-old lizard-like animal exhibited a bone condition similar to Paget's disease, indicating early susceptibility to the disorder. The study provides evidence of an ancient case of a bone metabolic disorder, shedding light on the evolution of diseases in early life forms.
Researchers have described a new treatment that could cope with Heterotopic Ossification and Fibrodysplasia Ossificans Progressiva using a PI3-kinase inhibitor. The study shows promising results in preclinical models, potentially leading to improved treatment options for patients.
A collaboration of researchers from Oregon State University, University of Oxford, and Erasmus University discovered a genetic mutation causing craniosynostosis, a condition where skull bones fuse prematurely. This finding may lead to the prevention of the disorder and a better understanding of its effects on other organ systems.
Recent advances in focal and sclerotic bone diseases have led to a clearer characterization of conditions like Paget's disease, fibrous dysplasia, and Camurati-Engelmann disease. This improved understanding has enabled the development of new therapeutic approaches for these disorders.
Researchers used protein sequence-based methods to diagnose an ancient and atypical form of Paget's disease in medieval skeletons. The study found extensive pathological changes, high disease prevalence, and low age-at-death estimations for affected skeletons.
Researchers found that a stem niche in the growth plate produces infinite numbers of cells, changing the concept of growth and potential treatment methods. The discovery may explain cases of unconstrained growth and provide new approaches to treating children with growth disorders.
A study found that just 45 minutes of patient education can significantly improve patients' attitudes and abilities in self-managing their chronic care. Patients reported increased confidence and reduced emotional distress after the brief instruction.
Scientists developed zebrafish with genetic mutations to study Saethre-Chotzen syndrome, a common form of craniosynostosis. The study revealed abnormal stem cell development leading to premature suture fusion and disrupted skull growth.
A study by St. Jude Children's Research Hospital and UCSF identified germline mutations in the genes SAMD9 or SAMD9L as responsible for a rare bone marrow disorder, myelodysplasia and leukemia syndrome with monosomy 7. The research found that some children with these mutations can spontaneously recover normal bone marrow function witho...
A study published in The Spine Journal found that one-third of people aged 40-59 have image-based evidence of moderate to severe degenerative disc disease. Additionally, the prevalence of spinal osteoarthritis increased significantly with age, particularly among women.
Researchers have discovered nine new genes associated with osteoarthritis, a degenerative disease causing joint damage and pain. The findings could lead to the development of targeted therapies for this debilitating condition, affecting 10 million people in the UK.
Researchers develop bone marrow models to study hematological and musculoskeletal disorders, focusing on regeneration and disease disturbance. The project aims to understand the relationship between blood and bone, leading to new regenerative therapies.
A recent Harvard University study reveals that knee osteoarthritis has dramatically increased in prevalence over the past 70 years, affecting an estimated one-third of Americans over 60. The research challenges the long-held assumption that osteoarthritis is simply a wear-and-tear disease related to aging and obesity.
A new study identifies key genes linked to the Galapagos cormorant's loss of flight, which shares similarities with human developmental disorders. The research suggests that shorter wings may have been advantageous during diving, reducing buoyancy and increasing survival.
Long-term bisphosphonate therapy for Paget's disease of bone found no significant clinical benefits, increasing fracture risk instead.
A new method of evaluation, using the cephalic width-intercoronal distance ratio, has been recommended to help determine when surgical intervention is needed for infants with fused cranial sutures. This measurement indicates a potential need for surgery in cases where the front and back of the skull are not proportionate.
A research team has identified mutations responsible for midline craniosynostosis, a type of skull-fusion disorder that affects the top of the skull. The study found that rare genetic variants in one gene interact with common changes near another gene to cause the disorder.
Brendan Lee receives 2016 Curt Stern Award for his groundbreaking work on human inborn errors of metabolism and structural birth defects of the skeleton. The award recognizes his significant scientific contributions over the past decade, including identifying genetic causes of chrondrodysplasia and Marfan syndrome.
A preclinical study shows that palovarotene, a repurposed drug, inhibits extra bone growth and preserves normal skeletal bone growth in mice with fibrodysplasia ossificans progressiva (FOP). The drug balances the effects of the FOP mutation, effectively restoring near-normal growth.
Researchers found no association between cesarean delivery and lower at-birth fracture rates in infants with osteogenesis imperfecta. The study, involving 540 patients, used large sample size to evaluate multiple covariates, revealing no differences in fracture rates based on delivery method.
Researchers investigate how mechanical loading affects bone strength and disease-related fragility by studying collagen's biological mechanism. The study aims to deliver new understanding of mechanically-induced adaptation in bone and provide ways to target bone disease through collagen modulation.
A study at Loyola University Medical Center found that knee replacements can treat degeneration caused by Blount disease, resulting in stable knees and no pain medications. Researchers used a scoring system to evaluate the success of the surgery, with mean scores indicating excellent range of motion and low disability.
Researchers will investigate coronal nonsyndromic craniosynostosis, a common birth defect causing facial and cranial dysmorphology. The study aims to identify new genes and networks driving this condition and develop a predictive computational model of head growth.
Researchers have identified a key role for Gli1+ stem cells in skull development and facial bone repair. Transplanting these stem cells into injured areas may help restore normal anatomy and facilitate brain growth, offering potential treatment options for infants with craniosynostosis and patients with facial disfigurement.
Researchers tracked over 2,500 Newark children to chart the progression of localized aggressive periodontitis, a genetic disease affecting 2% of African-American adolescents. The study aims to pinpoint biological markers in saliva that can predict bone loss and identify affected teeth.
The NIH has awarded $29 million to expand the Rare Diseases Clinical Research Network, a collaborative effort of physician scientists and patient advocacy groups. This funding will support clinical research and investigation of new treatments for patients with rare diseases, with a focus on improving diagnosis and treatment outcomes.
A study by St. Jude Children's Research Hospital found that dietary changes can alter the intestinal microbiome and susceptibility to autoinflammatory bone diseases. Researchers discovered that certain gut bacteria, such as Prevotella, fuel inflammation when fed a diet high in nutrients.
A new study published in Clinical Gastroenterology and Hepatology found that thiopurine therapy for inflammatory bowel disease (IBD) may increase the risk of myeloid disorders, including acute myeloid leukemia. The study analyzed data from over 19,000 IBD patients and found a seven-fold increased risk among those taking thiopurines.
Research found that one in three female triathletes suffer from urinary incontinence, bowel incontinence, or pelvic organ prolapse. High-impact sports like triathlon training can lead to decreased energy, menstrual irregularities, and abnormal bone density due to inadequate nutrition.
This review discusses four key physiologic processes in bone/tooth formation affected by rare bone diseases. The authors highlight causative mutations, etiopathology, and treatments for conditions like fibrous dysplasia, osteogenesis imperfecta, and hypophosphatasia.
Researchers developed a new way to study bone disorders and bone growth using stem cells from patients with a rare genetic bone disease. The approach identified a cellular mechanism driving abnormal bone growth and found chemicals that can slow it, potentially guiding future drug development.
Researchers discovered that Porphyromonas gingivalis produces an enzyme that enhances collagen-induced arthritis, leading to earlier onset and greater severity of rheumatoid arthritis. The bacteria worsens joint destruction by changing proteins into citrulline, triggering an immune attack.
Researchers at the University of Sheffield have developed a new treatment for children with brittle bone disease, finding that oral risedronate significantly reduces the risk of fractures. The study showed rapid action, with curves for fracture risk diverging after just 6 weeks of treatment.